6 years ago
A transplant of CRISPR-edited liver cells could replace lifelong injections for hemophilia B patients
A Salk Institute team transplanted liver cells into mouse models of hemophilia B, finding that the treatment restored their ability to form blood clots for a year. The hope is that this one-and-done treatment could replace the frequent injections of clotting factors that are currently used to treat the inherited blood disorder.
Continue Reading
https://www.fiercebiotech.com
Join the Discussion